BDSX FY 2023 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$49M+28.5% YoY

Gross Profit

$36M73.5% margin

Operating Income

-$41M-84.2% margin

Net Income

-$52M-106.2% margin

EPS (Diluted)

$-12.80

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$46M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$99M

Total Liabilities

$95M

Stockholders' Equity

$5M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$38M	+28.5%
Gross Profit	$36M	$24M	+50.0%
Operating Income	-$41M	-$51M	+18.3%
Net Income	-$52M	-$65M	+20.3%